ARTICLE | Clinical News
Aggrastat tirofiban hydrochloride: Extension study data
August 25, 2008 7:00 AM UTC
Merck published results in The Lancet from the double-blind, international On-TIME 2 trial in 936 evaluable patients showing that pretreatment with a high-bolus dose of Aggrastat met the primary endpo...